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Background  :  The  brachial-ankle  pulse  wave  velocity  (baPWV)  is  a  useful  parameter  to  assess  arterial  stiffness. 
However,  it  is  difficult  to  evaluate  arterial  stiffness  in  hypertensive  patients  because  the  baPWV  is  affected  by  the  blood 
pressure  itself.  This  study  was  designed  to  estimate  the  relationship  between  the  change  of  the  blood  pressure 
parameters  and  the  baPWV  (ΔbaPWV)  when  hypertensive  patients  were  subjected  to  an  acute  reduction  of  blood 
pressure. 
Methods  :  Thirty  patients  with  essential  hypertension  and  whose  blood  pressure  was  higher  than  140/90  mmHg 
were  enrolled.  In  all  the  patients,  the  blood  pressure  and  baPWV  were  measured  using  an  automatic  waveform 
analyzer  with  the  patients  at  a  resting  state.  When  the  reduction  of  blood  pressure  was  more  than  10  mmHg  after 
sublingual  administration  of  nifedipine  10  mg,  then  the  blood  pressure  and  baPWV  were  measured  again  in  the  same 
manner  and  then  they  were  compared  with  the  baseline  values.  Spearman's  correlation  and  multiple  linear  regression 
tests  were  performed  to  estimate  the  relationship  between  the  change  of  the  blood  pressure  parameters  (ΔSBP,  Δ
DBP,  ΔMAP  and  ΔPP)  and  the  ΔbaPWV.
Results  :  The  baPWV  was  significantly  decreased  shortly  after  the  administration  of  nifedipine  (1903.6±305.2 
cm/sec  vs.  1716±252.0  cm/sec,  respectively,  p<0.01).  The  ΔbaPWV  was  correlated  with  the  ΔSBP  (r=0.550,  p<0.01), 
ΔDBP  (r=0.386,  p<0.05),  ΔMAP  (r=0.441,  p<0.05),  and  ΔPP  (r=0.442.  p<0.05).  On  the  multiple  regression  analysis,  the 
ΔSBP  was  the  only  significant  variable  for  predicting  the  ΔbaPWV,  and  the  linear  equation  was  ΔbaPWV=8.7×
SBP-48.
Conclusions  :  The  baPWV  is  affected  by  the  systolic  blood  pressure  level  to  a  large  degree  and  careful  attention 
must  be  paid  to  the  blood  pressure  level  when  evaluating  arterial  stiffness  with  using  the  baPWV. 
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INTRODUCTION
Pulse  wave  velocity  is  a  noninvasive  parameter  that's  used 
to  evaluate  arterial  stiffness  and  it  is  an  independent  predictor  of 
the  risk  for  cardiovascular  disease
1-4).  A  new  device  that  can 
simply  measure  the  PWV  by  simultaneous  oscillometric 
measurement  of  the  pulse  wave  in  all  four  extremities 
(brachial-ankle  pulse  wave  velocity,  baPWV)  has  recently  been The  Korean  Journal  of  Internal  Medicine  :  Vol.  22,  No.  3,  September  2007 148
Age,  years
Male  gender,  n  (%)
Body  mass  index,  kg/m
2
Systolic  blood  pressure,  mmHg
Diastolic  blood  pressure,  mmHg
Mean  arterial  pressure,  mmHg
Pulse  pressure,  mmHg
Heart  rate,  bpm
Ankle-brachial  index
62.9±10.9
7  (23)
26.3±2.9
167.7±10.9
90.5±12.4
118.0±12
77.2±10.8
67.3±13.5
1.11±0.09
Table 1. The baseline characteristics and hemodynamic parameters 
of  the  enrolled  hypertensive  patients  (n=30)
developed.  This  method  is  fairly  reproducible  and  it  is  well 
correlated  with  the  conventional  central  PWV
5-9).  The  baPWV, 
which  was  confirmed  in  large  clinical  trials  as  a  parameter  of 
arterial  stiffness,  is  a  useful  screening  method  for  evaluating  the 
atherosclerotic  risk
10-14). 
Age,  gender  and  blood  pressure  are  the  major  determinants 
of  the  PWV
1, 6-8, 14-16).  Among  these,  blood  pressure  is  affected 
by  various  conditions  such  as  the  surrounding  environment, 
emotional  stress  and/or  physical  activities.  Although  attempts  to 
correct  the  baPWV  via  the  blood  pressure  have  been  done  in 
several  studies  in  order  to  estimate  the  absolute  risk  of 
atherosclerotic  cardiovascular  diseases
1, 6, 16-18),  there  is  currently 
no  data  about  the  effects  of  acute  changes  of  the  blood 
pressure  on  the  baPWV  in  one  subject.  In  the  present  study, 
we  evaluated  the  relationship  between  the  change  of  several 
blood  pressure  parameters  and  the  baPWV  with  an  acute 
reduction  of  blood  pressure  after  the  administration  of  sublingual 
nifedipine.
MATERIALS AND METHODS
Subjects
The  total  of  30  consecutive  subjects  were  recruited  from 
those  patients  who  were  newly  diagnosed  with  essential 
hypertension  and  whose  blood  pressure  was  higher  than  140/90 
mmHg.  The  medical  history  and  symptoms  of  each  subject 
were  confirmed  by  the  consulting  doctor.  All  the  subjects  had  a 
normal  ankle-brachial  index  (ABI  >0.9)  and  they  were  without 
any  medical  history  of  diabetes  mellitus  or  renal  insufficiency.
Methods
The  baseline  blood  pressure  and  baPWV  were  measured  in 
all  the  patients  with  using  a  volume-plethysmographic  apparatus 
(PWV/ABI,  Colin  Co.  Ltd.).  This  instrument  can  simultaneously 
record  profiles  of  several  variables  such  as  the  PWV,  the  blood 
pressure  parameters  (systolic  blood  pressure,  diastolic  blood 
pressure,  mean  arterial  pressure  and  pulse  pressure),  the  heart 
rate  and  the  ABI.  Nifedipine  10  mg  was  administered 
sublingually  to  all  the  patients  and  the  blood  pressure  was 
measured  every  10  minutes.  When  the  reduction  of  the  blood 
pressure  was  more  than  10  mmHg,  then  the  same  profiles  were 
rechecked  for  making  comparison  with  the  values  measured 
before  and  after  the  administration  of  nifedipine.  If  the  systolic 
blood  pressure  did  not  fall  by  more  than  10  mmHg  for  30 
minutes,  then  sublingual  nifedipine  10mg  was  administered  once 
more.  All  the  procedures  were  supervised  by  doctors  who 
monitored  the  subjects'  signs  and  symptoms  and  their  blood 
pressure. 
Statistics
The  data  was  expressed  as  means±SDs.  Statistical  analysis 
was  performed  using  the  SPSS  11.5  software  program.  The 
changes  of  the  blood  pressure  parameters  (ΔSBP,  ΔDBP,  Δ
MAP  and  ΔPP),  heart  rate  (ΔHR),  and  the  baPWV  (ΔbaPWV) 
between  before  and  after  the  administration  of  nifedipine  were 
evaluated  by  using  the  non-parametric  Wilcoxon  Signed  Rank 
test.  Spearman's  Rho  correlation  test  was  performed  to 
evaluate  the  relationships  among  the  changes  of  the  blood 
pressure  parameters,  the  heart  rate  and  the  baPWV.  Univariate 
and  multiple  linear  regression  tests  (the  stepwise  method)  were 
also  performed  to  estimate  the  association  between  the  change 
of  the  blood  pressure  parameters  and  that  of  the  baPWV.  A  p 
value  below  0.05  was  considered  statistically  significant.
RESULTS
The  clinical  characteristics  and  hemodynamic  parameters  of 
the  subjects  are  shown  in  Table  1.  The  subjects'  mean  age  was 
62.9±10.9  years  and  7  of  the  30  patients  were  male.  Table  2 
depicts  the  change  of  the  blood  pressure  parameters,  the  heart 
rate  and  the  baPWV  after  administration  of  nifedipine.  All  of  the 
blood  pressure  parameters  and  the  baPWV  were  acutely 
decreased  for  a  brief  period  of  time  and  in  contrast,  the  heart 
rate  was  significantly  increased.  In  30  patients,  the  mean 
change  of  systolic  blood  pressure  was  27±13  mmHg  and  that 
of  the  baPWV  was  187±189  cm/sec.  The  ΔSBP,  ΔDBP,  Δ
MAP  and  ΔPP  between  before  and  after  the  administration  of 
nifedipine  were  well  correlated  with  the  ΔbaPWV,  but  the  ΔHR 
was  not  correlated  with  the  ΔbaPWV  (Table  3).  On  univariate 
linear  regression  analysis,  the  ΔSBP,  ΔDBP  and  ΔMAP  were 
the  significant  variables  for  predicting  the  ΔbaPWV.  However, 
the  ΔDBP  and  ΔMAP  showed  weak  partial  correlation  with  the 
ΔbaPWV  if  the  ΔbaPWV  was  adjusted  by  the  ΔSBP,  and 
then  these  2  factors  were  excluded  because  of  their  statistical 
insignificance  on  the  multiple  linear  regression  analysis  by  the 
stepwise  method  (Table  4).  Finally,  the  linear  equation  was 
acquired  as  ΔbaPWV=8.7×ΔSBP-48  (Figure  1).   Hun-Jun  Park,  et  al  :  Acute  effects  of  blood  pressure  on  the  baPWV 149
Before  Nifedipine After  Nifedipine ∆Mean p-values
SBP,  mmHg
DBP,  mmHg
MAP,  mmHg
PP,  mmHg
HR,  bpm
baPWV,  cm/sec
160.7±10.9
90.5±12.4
118.0±12.0
77.2±10.8
67.3±13.5
1903.6±305.2
140.6±14.5
80.7±10.6
102.4±12.0
59.9±8.9
72.6±12.3
1716.0±252.0
27.1±13.0
9.8±9.2
15.6±10.2
17.2±9.5
-5.3±9.0
187±189
<0.001
<0.001
<0.001
<0.001
0.003
<0.001
∆,  difference  between  before  and  after  the  administration  of  nifedipine;  SBP,  systolic  blood  pressure;  DBP,  diastolic  blood  pressure; 
MAP,  mean  arterial  pressure;  PP,  pulse  pressure:  HR,  heart  rate:  baPWV,  brachial‐ankle  pulse  wave  velocity
Table  2.  Comparison  of  the  hemodynamic  parameters  and  the  baPWV  between  before  and  after  administration  of  nifedipine
Variable ∆SBP ∆DBP ∆MAP ∆PP ∆HR
∆baPWV 0.550
** 0.38
6* 0.441
* 0.442
* -0.066
∆,  difference  between  before  and  after  the  administration  of  nifedipine;  SBP,  systolic  blood  pressure;  DBP,  diastolic  blood  pressure; 
MAP,  mean  arterial  pressure;  PP,  pulse  pressure:  HR,  heart  rate;  baPWV,  brachial‐ankle  pulse  wave  velocity.  **p<0.01,  *p<0.05.
Table  3.  Correlation  coefficients  (r):  Correlations  between  the  change  in  the  baPWV  and  the  hemodynamic  parameters
Variable
Univariate Mutivariate  (stepwise)
r
2 p  value Standard  β p  value
Age,  years
Male  gender
BMI,  kg/m
2
∆SBP
∆DBP
∆MAP
∆PP
∆HR
ABI
0.097
0.000
0.016
0.356
0.241
0.336
0.116
0.017
0.018
0.094
0.925
0.506
0.001
0.006
0.001
0.066
0.498
0.485
0.596
Excluded
*
Excluded
*
0.001
*Excluded  variables
Variable Beta  in t p  value Partial  correlation
∆DBP
∆MAP
0.160
0.257
0.770
0.859
0.448
0.398
0.147
0.163
Table  4.  Univariate  and  multivariate  regression  analysis  to  predict  the  change  of  the  baPWV
Figure  1.  Correlation  between  the  change  of  systolic  blood 
pressure  and  the  baPWV.
DISCUSSION
Age,  gender  and  systolic  blood  pressure  are  known  to  be  the 
major  determinants  of  the  baPWV
1, 6-8, 14-16).  In  a  previous  study, 
the  baPWV  was  lower  in  females  than  in  males  until  the  age  of 
60  and  it  became  similar  in  both  genders  over  the  age  of  60. 
The  relationship  between  age  and  baPWV  demonstrated  a 
quadratic  curve  for  both  genders
15).  Blood  pressure,  which  is 
both  changeable  and  modifiable,  is  also  a  major  determinant  of 
the  baPWV  for  evaluating  the  arterial  stiffness.  The  blood 
pressure  is  affected  by  various  conditions  such  as  the 
surrounding  environment,  emotional  stress  and/or  physical 
activities.  Therefore,  it  is  difficult  to  discriminate  whether  the 
measured  baPWV  reflects  only  an  elevated  blood  pressure  or  it 
increases  the  potential  risk  for  atherosclerotic  cardiovascular 
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disease,  and  especially  in  those  patients  with  high  blood 
pressure.  In  other  words,  the  baPWV  may  under-  or 
overestimate  the  real  potential  risk  for  atherosclerotic 
cardiovascular  disease  if  it  is  not  corrected  by  the  blood 
pressure  level.  There  have  been  several  studies  that  attempted 
to  correct  the  PWV  in  patients  by  altering  their  blood  pressure. 
Asmar  et  al
1)  reported  on  a  simple  linear  equation  to  obtain  the 
carotid-femoral  PWV,  and  this  equation  was  derived  from  the 
systolic  blood  pressure  and  age.  Kubo  et  al
6)  also  reported  a 
regression  equation  that  was  derived  from  the  mean  systolic 
pressure  and  age  by  gender.  Yamashina  et  al  studied  5302 
subjects  with  either  normal  blood  pressure  or  with  high  blood 
pressure  and  they  were  without  other  atherosclerotic  risk 
factors,  and  these  researchers  created  a  nomogram  of  the 
relation  of  the  baPWV  with  blood  pressure  and  then  applied  it 
to  297  subjects  with  coronary  heart  disease
16).  Yet  there  have 
been  no  studies  about  the  changes  of  baPWV  in  one  subject 
when  there  is  an  acute  reduction  of  blood  pressure.  The 
present  study  confirmed  that  the  difference  of  systolic  blood 
pressure  between  before  and  shortly  after  the  administration  of 
nifedipine  was  positively  correlated  with  the  change  of  the 
baPWV.  We  believed  that  there  were  no  changes  in  the 
conditions  when  measuring  the  baPWV  except  for  the  blood 
pressure.  This  fact  may  suggest  that  the  baPWV  is  a  reflection 
of  the  blood  pressure  to  a  large  degree.  Using  multiple  linear 
regression  analysis,  we  also  acquired  a  linear  equation  that  can 
quantify  the  relation  between  the  change  of  systolic  blood 
pressure  and  the  baPWV.  This  relationship  might  be  useful  to 
calibrate  the  change  of  blood  pressure,  especially  when 
assessing  the  efficacy  of  antihypertensive  agents  for  treating 
arterial  stiffness.
The  findings  of  our  study  have  to  be  interpreted  in  light  of  the 
following  limitation.  First,  we  used  the  calcium  channel  blocker 
nifedipine  (10  mg),  which  had  an  influence  on  the  PWV  by 
lowering  the  blood  pressure  through  a  vasodilatory  effect. 
However,  there  are  various  types  of  antihypertensive  drugs  that 
have  different  mechanisms  to  lower  blood  pressure  and  they 
have  different  effects  on  the  baPWV.  We  didn't  compare  the 
acute  effect  of  blood  pressure  on  the  baPWV  according  to  the 
types  of  antihypertensive  drugs.  Second,  because  the  linear 
equation  was  acquired  in  a  study  that  examined  only  30 
hypertensive  patients,  a  larger  sample  size  may  be  needed  to 
validate  and  strengthen  the  statistical  power  of  the  equation.
In  this  study,  we  concluded  that  the  baPWV  is  affected  by 
the  systolic  blood  pressure  level  to  a  large  degree,  and  careful 
attention  must  be  paid  to  the  blood  pressure  level  when 
evaluating  arterial  stiffness  with  using  the  baPWV. 
REFERENCES
  1) Asmar  R,  Bentos  A,  Topouchian  J,  Laurent  P,  Pannier  B,  Brisac 
AM,  Target  R,  Levy  BI.  Assessment  of  arterial  distensibility  by 
automatic  pulse  wave  velocity  measurement:  validation  and  clinical 
application  studies.  Hypertension  26:485-490,  1995
  2) Laurent  S,  Boutouyrie  P,  Asmar  R,  Gautier  I,  Laloux  B,  Guize  L, 
Ducimetiere  P,  Benetos  A.  Aortic  stiffness  is  an  independent 
predictor  of  all-cause  and  cardiovascular  mortality  in  hypertensive 
patients.  Hypertension  37:1236-1241,  2001
  3) Blacher  J,  Guerin  AP,  Pannier  B,  Marchais  SJ,  Safar  ME,  London 
GM.  Impact  of  aortic  stiffness  on  survival  in  end-stage  renal  disease. 
Circulation  99:2434-2439,  1999
  4) van  Popele  NM,  Grobbee  DE,  Bots  ML,  Asmar  R,  Topouchian  J, 
Reneman  RS,  Hoeks  AP,  van  der  Kuip  DA,  Hofman  A,  Witteman 
JC.  Association  between  arterial  stiffness  and  atherosclerosis.  Stroke 
32:454-460,  2001
  5) Yamashina  A,  Tomiyama  H,  Takeda  K,  Tsuda  H,  Arai  T,  Hirose  K, 
Koji  Y,  Hori  S,  Yamamoto  Y.  Validity,  reproducibility  and  clinical 
significance  of  noninvasive  brachial-ankle  pulse  wave  velocity 
measurement.  Hypertens  Res  25:359-364,  2002
  6) Kubo  T,  Miyata  M,  Minagoe  S,  Setoyama  S,  Maruyama  I,  Tei  C.  A 
simple  oscillometric  technique  for  determining  new  indices  of  arterial 
distensibility.  Hypertens  Res  25:351-358,  2002
  7) Munakata  M,  Ito  N,  Nunokawa  T,  Yosinaga  K.  Utility  of  automated 
brachial  ankle  pulse  wave  velocity  measurements  in  hypertensive 
patients.  Am  J  Hypertens  16:653-657,  2003
  8) Matsui  Y,  Kario  K,  Ishikawa  J,  Eguchi  K,  Hoshide  S,  Shimada  K. 
Reproducibility  of  arterial  stiffness  indices  (pulse  wave  velocity  and 
augmentation  index)  simultaneously  assessed  by  automated  pulse 
wave  analysis  and  their  associated  risk  factors  in  essential 
hypertensive  patients.  Hypertens  Res  27:851-857,  2004
  9) Cortez-Cooper  MY,  Supak  JA,  Tanaka  H.  A  new  device  for 
automatic  measurements  of  arterial  stiffness  and  ankle-brachial 
index.  Am  J  Cardiol  91:1519-1522,  2003
10) Takami  T,  Shigemasa  M.  Efficacy  of  various  antihypertensive  agents 
as  evaluated  by  indices  of  vascular  stiffness  in  elderly  hypertensive 
patients.  Hypertens  Res  26:609-614,  2003
11) Ichihara  A,  Hayashi  M,  Koura  Y,  Tada  Y,  Hirota  N,  Saruta  T.  Long- 
term  effects  of  intensive  blood  pressure  lowering  on  arterial  wall 
stiffness  in  hypertensive  patients.  Am  J  Hypertens  16:959-965,  2003
12) Munakata  M,  Nagasaki  A,  Nunokawa  T,  Sakuma  T,  Kato  H, 
Yoshinaga  K,  Toyota  T.  Effects  of  valsartan  and  nifedipine  coat-core 
on  systemic  arterial  stiffness  in  hypertensive  patients.  Am  J 
Hypertens  17:1050-1055,  2004
13) Uchida  H,  Nakamura  Y,  Kaihara  M,  Sugimoto  T,  Norii  H,  Sasaki  M, 
Sato  H,  Makino  H.  Practical  efficacy  of  telmisartan  for  decreasing 
morning  home  blood  pressure  and  pulse  wave  velocity  in  patients 
with  mild-to-moderate  hypertension.  Hypertens  Res  27:545-550, 
2004
14) Chuang  SY,  Chen  CH,  Cheng  CM,  Chou  P.  Combined  use  of 
brachial-ankle  pulse  wave  velocity  and  ankle-brachial  index  for  fast 
assessment  of  arteriosclerosis  and  atherosclerosis  in  a  community. 
Int  J  Cardiol  98:99-105,  2005
15) Tomiyama  H,  Yamashina  A,  Arai  T,  Hirose  K,  Koji  Y,  Chikamori  T, 
Hori  S,  Yamamoto  Y,  Doba  N,  Hinohara  S.  Influences  of  age  and 
gender  on  results  of  noninvasive  brachial-ankle  pulse  wave  velocity Hun-Jun  Park,  et  al  :  Acute  effects  of  blood  pressure  on  the  baPWV 151
measurement-a  survey  of  12517  subjects.  Atherosclerosis  166:303- 
309,  2003
16) Yamashima  A,  Tomiyama  H,  Arai  T,  Koji  Y,  Yambe  M,  Motobe  H, 
Glunizia  Z,  Yamamoto  Y,  Hori  S.  Nomogram  of  the  relation  of 
brachial-ankle  pulse  wave  velocity  with  blood  pressure.  Hypertens 
Res  26:801-806,  2003
17) Yambe  T,  Yoshizawa  M,  Saijo  Y,  Yamaguchi  T,  Shibata  M,  Konno 
S,  Nitta  S,  Kuwayama  T.  Brachio-ankle  pulse  wave  velocity  and 
cardio-ankle  vascular  index  (CAVI).  Biomed  Pharmacother  58(Suppl 
1):S95-S98,  2004 
18) Shirai  K,  Utino  J,  Otsuka  K,  Takata  M.  A  novel  blood  pressure- 
independent  arterial  wall  stiffness  parameter:  cardio-ankle  vascular 
index  (CAVI).  J  Atheroscler  Thromb  13:101-107,  2006